Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer

Dendritic cell (DC)–based T-cell activation is an alternative immunotherapy in breast cancer. The anti-programmed death ligand 1 (PD-L1) can enhance T-cell function. Nucleolin (NCL) is overexpressed in triple-negative breast cancer (TNBC). The regulation of PD-L1 expression through autophagy and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thongchot, Suyanee, Jirapongwattana, Niphat, Luangwattananun, Piriya, Chiraphapphaiboon, Wannasiri, Chuangchot, Nisa, Sa-nguanraksa, Doonyapat, O-Charoenrat, Pornchai, Thuwajit, Peti, Yenchitsomanus, Pa-thai, Thuwajit, Chanitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Small Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377762/
https://www.ncbi.nlm.nih.gov/pubmed/35313339
http://dx.doi.org/10.1158/1535-7163.MCT-21-0823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377762/
https://www.ncbi.nlm.nih.gov/pubmed/35313339
http://dx.doi.org/10.1158/1535-7163.MCT-21-0823

Ejemplares similares